drugset / Trial / NCT06355401
Maintenance Hormonal Therapy and DLBCL
RandomizedParallel-groupDouble-blindTreatment
Summary
the study aims to detect the benefit of maintenance tamoxifen after achieving CR with conventional immuno-chemotherapy and/or radiotherapy in patients with DLDCL
Timeline
- Start
- 2024-04
- Primary completion
- 2026-03
- Completion
- 2029-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tamoxifen | Small molecule | 20 mg | — |